Mitochondrial single nucleotide polymorphisms (mtSNPs) have been reported to associate with type-2 diabetes mellitus (T2DM), but mtSNPs appear to be considerably different among different populations and regions. To determine mtSNPs in Chinese Han patients with T2DM, the entire sequences of the mitochondrial genomes from 72 T2DM Chinese (59 ± 4 years) and 50 age-matched healthy subjects (controls) in Chongqing region of Western China were directly sequenced and mtSNPs were analyzed. We found that M8, M9, D, G, R and A haplogroups exist in Chinese Han population and the frequency of haplogroup M9 was significantly higher in patients with T2DM than in the controls ( p = 0.0006, OR 0.06 [95% CI 0.008-0.476]). MtSNPs T3394C in NADH dehydrogenase subunit 1 (ND1), G4491A in ND2, T16189C and T16519C were found with significantly higher frequency in patients with T2DM than in the controls (T16189C, p = 0.0045; T16519C, p < 0.0001; T3394C, p = 0.0015; G4491A, p = 0.0015). In contrast, the frequency of C5178A in ND2 and A10398G in ND3 was higher in the controls than in patients with T2DM (C5178A, p = 0.014; A10398G, p = 0.0011). Our results indicate that mtSNPs T3394C, G4491A, T16189C and T16519C show susceptible tendency to T2DM and mtSNPs C5178A and A10398G seem to be genetic factors for against T2DM. These mtSNPs determined in our study is useful and could be used for early diagnosis and prevention of T2DM in Chinese Han population.
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Tohoku J. Exp. Med., 2008 , 215 (4), 377-384. © 2008 Type 2 diabetes mellitus (T2DM) is a common metabolic disorder characterized by impaired insulin secretion from pancreatic beta cells and reduced insulin action or insulin resistance in the peripheral tissue. Mitochondria play a key role in biogenesis, in glucose metabolism and in adenosine-5′-triphosphate (ATP) production, which has been linked to insulin secretion in pancreatic beta cells (Maechler and Wollheim 2001; Cortassa et al. 2003) . It has been reported that variants in mitochondria deoxyribonucleic acid (mtDNA) are associated with T2DM and its traits (Bhat et al. 2007a, b; Liou et al. 2007; Szendroedi et al. 2007 ).
Chinese subjects, but did not observe significant association between T2DM and 5178A/C polymorphisms. Fuku's group performed a large-scale association study and showed that mitochondrial haplogroup N9a was significantly associated with resistance against T2DM, and all three mtSNPs for determination of N9a, G5231A, A12358G and G12372A, were closely involved in T2DM process .
Although many mtDNA mutations have been found to be associated with T2DM, there are some controversial observations, which is probably due to the different populations and/or different methods. In the present study, we sequenced the entire mtDNA of 72 Chinese Han subjects with T2DM and 50 healthy controls and analyzed the mitochondrial haplogroups or mtDNA mutations, and thus examined the possible association of these mutations with T2DM.
PATIENTS AND METHODS
The study population comprised 132 Han Chinese subjects. 72 patients with T2DM aged ≥ 50 years were enrolled from the population of individuals who had visited outpatient clinics of Southeast Hospital of Chongqing Third Military Medical University, China. The patients with T2DM had fasting plasma glucose (FPG) concentration of ≥ 7.0 mmol/liter (126 mg/dl) and/or blood glycosylated hemoglobin (HbA1c) level of ≥ 6.5% or were taking antidiabetes medication. T2DM was defined according to the criteria accepted by the World Health Organization. The 50 control subjects had an FPG concentration of < 6.1 mol/liter (110 mg/dl) and a blood HbA1c level of < 5.6%, and they had no history of T2DM or of taking antidiabetes medication. All subjects were examined in the morning after an overnight fast. The characteristics of subjects are shown in Tables 1. All experiments were performed in compliance with the relevant laws and our institutional guidelines. Informed consent was obtained from patients that participated in the study.
Venous blood (5 ml) was collected from each subject into tubes containing 50 mM ethylenediaminetetraacetic acid (EDTA), disodium salt, and genomic DNA was isolated with the use of a commercial kit (QIAmp DNA Blood Midi Kit, Qiagen Inc., Valencia, CA, USA). The mitochondrial DNA was amplified by long polymerase chain reaction (PCR) using specific primers to Mitochondria have their own DNA, mitochondrial DNA (mtDNA), which encodes the genes of 22 transfer ribonucleic acids (tRNAs), 2 ribosomal RNAs (rRNAs), and 13 subunits of enzymes related to oxidative phosphorylation (Anderson et al., 1981) . Mitochondrion is a major source of free radicals with poor DNA repair enzyme system. Under the constant reactive oxygen species (ROS) stress, mtDNA appears very high mutation frequency and is highly polymorphic. Besides diabetes mellitus, mtDNA polymorphisms have been reported to associated with some other complex diseases such as Alzheimer disease (Crouch et al. 2007 ), Parkinson disease (Luoma et al. 2007; Mortiboys et al. 2007 ), bipolar disorder (Kato et al. 2001) , maternally inherited diabetes and deafness (MIDD) (Kokotas et al. 2007 ), cardiac infarction (Mukae et al. 2003; Takagi et al. 2004; Nishigaki et al. 2007) , and some kinds of cancer (Canter et al. 2005) .
There have been numerous reports of association between mtDNA variants and T2DM and its intermediate traits. Mitochondrial single nucleotide polymorphisms (mtSNPs) C1310T, A1382C, G1438A, A1202G, A3252G, A3256T, A3264C, A3271C, T3290C, C3303T, G3316A, T3394C, A5178C, A8296G, A8344G, A10398G, G11778A, A12026G, C12258A, T14577C, T14709C, T16519C, A14693G and T16189C etc have been reported to be associated with T2DM (Tawata et al. 2000; Mohlke et al. 2005; Salles et al. 2007; Liou et al. 2007; Bhat et al. 2007a, b) . Most of these variants are rare and many are associated with additional traits such as deafness, neurological symptoms, or myopathy. Individuals with one common variant, T16189C, have an increasing risk of T2DM, higher fasting insulin levels and lower ponderal index (Bhat et al. 2007a, b) . Japanese either in haplogroup M8a characterized by C8684T or in haplogroup B4c by T3497C and T1119C show significant susceptibility to T2DM and obsesity (Guo et al. 2005) .
Recently several other mtDNA variants have been reported to be associated with T2DM. Liu et al. (2007) showed an association with the T3394C and A12026G mutations on over 476 mitochondrial DNA (Table 2 ). The reaction mixture (50 μ l) contained 300 ng of genomic DNA, 5 pmol of each primer, 0.2 mM of each deoxynucleoside triphosphate, 2.5 mM magnesium chloride (MgCl 2 ), and 1 U of DNA polymerase (Platinum ® Taq DNA Polymerase High Fidelity, Invitrogen Corp., Carlsbad, CA, USA) in the PCR buffer supplied by the manufacturer. The amplification protocol consisted of an initial denaturation at 95°C for 3 min followed by 35 cycles of denaturation at 95°C for 20 s, annealing at 55°C for 40 s, and extension at 72°C for 4.5 min, with a final extension at 72°C for 10 min. The PCR products containing the entire mitochondrial genome were purified and then sequenced using the DYEnamic ET terminator cycle sequencing premix kit (Applied Biosystems ABI 3730xl, Foster City, CA, USA). The primers used for sequencing were listed in supplement Table 1 .
MtDNA polymorphism and haplogroups analysis were carried out according to the Cambridge Reference Sequence (CRS) (Anderson et al. 1981; Andrews et al. 1999; Finnila et al. 2001; Herrnstadt et al. 2002) .
Quantitative clinical data were compared between patients with T2DM and control individuals by use of the unpaired Student's t test. Allele and haplogroup frequencies between patients with T2DM and control individuals were evaluated through a χ 2 test. A value of p < 0.05 was considered statistically significant.
RESULTS
The characteristics of 132 subjects are shown in Table 1 . Body mass index (BMI), serum concentration of triglycerides and blood level of HbA1c were significantly higher in patients with T2DM than in the controls ( p < 0.0001). The serum concentration of high density lipoprotein (HDL) cholesterol was lower in patients with T2DM than in the controls ( p < 0.0001).
The entire mtDNA genome from 132 subjects was sequenced separately and mtDNA polymorphism was analyzed. Six haplogroups M8, M9, D, G, R and A were identified in these subjects (Table 3 ). The frequency of haplogroup M9 was significantly higher in patients with T2DM than in the controls ( p = 0.0006, OR 0.06 [95% confidence level (CI) 0.008-0.476]). This result 1.55 ± 0.13 1.83 ± 0.20 *** HDL cholesterol (mM)
1.32 ± 0.36 1.22 ± 0.14 *** HbA1c (%) 4.9 ± 0.7 7.9 ± 1.9 *** Values are given as means ± SDs, ***: p < 0.0001 vs CTL (control).
suggested that subjects in the mitochondria haplogroup M9 tended to have an increased risk of T2DM. Next, the possible relationship between the mitochondria DNA single nucleotide polymorphisms (mtSNPs) and T2DM was examined. The frequency of two mtSNPs specifically used for determination of haplogroup M9, T3394C and G4491A, showed significant differences between the subjects with T2DM and the controls (T3394C: p = 0.0015, OR 0.07 [95% CI 0.01-0.56]; G 4 4 9 1 A : p = 0 . 0 0 1 5 , O R 0 . 0 7 [ 9 5 % C I 0.01-0.56]). MtT3394C mutation causes an amino acid change from Y to H within the nicotinamide adenine dinucleotide (NADH) dehydrogenase 1 (ND1) and mtG4491A mutation from V to I within ND2 (Table 4 ). The frequency of both two mtSNPs was higher in patients with T2DM than in the controls.
MtT16189C and T16519C variants within D-Loop region were found with significantly higher prevalence in patients with T2DM than in the controls (T16189C: p = 0.0045, OR 0.32 [95% CI 0.14-0.71]; T16519C: p < 0.0001, OR 0.13 [95% CI 0.05-0.33]). According to the combined analysis of these three mtSNPs mentioned above, we speculated that these mtSNPs were closely associated with the susceptibility to T2DM. An asterisk denotes means the significance at the 95% confidence level (**: p < 0.001). In addition, we also found several other mtSNPs which probably provide protection against T2DM. MtC5178A causes an amino acid change from Leu to Met within the ND2 gene and mtA10398G from threonine to alanine within the ND3 gene. The frequency of these two mtSNPs was significantly higher in the controls than in patients with T2DM, respectively (C5178A: p = 0.014, OR 4.25 [95% CI 1.25-14.45; A10398G: p = 0.0011, OR 3.52 [95% CI 1.63-7.61]). These observations provided strong evidence that these genotype backgrounds, either together or independently, may resist the onset of type 2 diabetes.
DISCUSSION
Type 2 diabetes Mellitus (T2DM) is the single most important metabolic disease and now is becoming a major health burden worldwide. Although the detailed mechanisms induced T2DM are not fully clarified up to date, emerging evidences suggested that variants in mtDNA play a crucial role in the process of T2DM (Bhat et al. 2007b; Liou et al. 2007; Szendroedi et al. 2007 ). In our study, we revealed that mtDNA haplogroup M9 tended to increase the susceptibility to T2DM in Chinese Han population. T3394C mutation occurred in NADH dehydrogenase subunit 1 (ND1) and G4491A in ND2. These two mutations of mtDNA specifically characteristic to haplogroup M9 caused amino acids changes: T3394C causing amino acid change from tyrosine (Y) to histidine (H) and G4491A from valine (V) to isoleucine (I), which would be considered potentially functional polymorphisms. Tyrosine belongs to polarity and neutral amino acid, whereas histidine belongs to base amino acid, these amino acid changes, especially Y to H, potentially can induce the conformational changes of NADH dehydrogenase and thus might influence the function of the NADH dehydrogenase and oxidative phosphorylation system in mitochondria. The actual effect of these mutations on mitochondrial function remains to be investigated.
MtDNA is a maternally inherited 16,568-bp haploid genome without inner codes that encode 13 units of the respiratory chain complexes and appears rather high mutation frequency.
Mitochondria play an integral role in biogenesis, glucose metabolism and insulin secretion, mtDNA variants are potential candidates for contributing to diabetes process.
So far, many mtDNA variants and mtDNA haplogroups have been reported to be associated with T2DM. Guo et al revealed that Japnese either in haplogroup M8a characterized by C8684T or in haplogroup B4c by T3497C and T1119C has an increasing risk to T2DM and obsesity (Guo et al. 2005) . In Finns population, haplogroup J conferred susceptibility to T2DM (Mohlke et al. 2005) . Most recently, haplogroup N9a has been reported to act as an independent protective factor against T2DM for both Korean and Japanese subjects. Japnese subjects in haplogroup F and Korean subjects in haplogroup D5 or D4b also showed a increased risk of T2DM ). However, in our study, haplogroup M9 tended to confer susceptibility to T2DM. Taken together, these findings suggested that the contributions of mtDNA heredity appear to differ considerably between different populations and different regions.
Many mtDNA mutations that have been suggested to be associated with DM (Mohlke et al. 2005; Bhat et al. 2007b; Liou et al. 2007; Salles et al. 2007 ). Many studies have revealed that SNP T16189C correlated with T2DM and metabolic syndrome (Mohlke et al. 2005; Weng et al. 2005; Navaglia et al. 2006; Tang et al. 2006; Bhat et al. 2007b; Liou et al. 2007 ). Bhat et al. (2007b) showed that mt10398A and 16189C provide susceptibility to T2DM independently and further they revealed that mt10398G and 16189T could provide protection against T2DM in North Indian populations. In addition, the association of mtDNA T16189C variant with T2DM or metabolic syndrome in Chinese subjects has been reported previously (Weng et al. 2005; Tang et al. 2006) . These findings are consistent with our observations that the prevalence of T16189C is significantly higher in T2DM subjects than in controls ( p = 0.011), and A10398G with a higher frequency in controls than in T2DM subjects ( p = 0.0004).
Tang et al demonstrated that T3394C and A14693G variants probably contributed to predis-position to T2DM, and T16189C is associated with insulin resistance in Chinese Han population (Tang et al. 2006) . Recently, Liu et al in 2007 also showed that T3394C and A12026G might be associated with T2DM in Chinese Han population, but no significant association of C5178A with T2DM was observed (Liu et al. 2007 ). Navaglia et al revealed that T16519C is a predisposing genetic factor for DM (Navaglia et al. 2006) . In our study, we found that T3394C and T16519C variants, other than A14693G and A12026G, showed a significant predisposition to T2DM. To the contrary to Liu's report about C5178A, we found C5178A variant tended to confer protection against T2DM process, which is consistent with previous report that mt5178A genotype may resist the onset of T2DM (Kokaze et al. 2005) .
Several methods, such as restriction fragment length polymorphism PCR (RFLP-PCR), allele-specific PCR (AS-PCR), real-time PCR, xMAP and mtDNA sequencing technology, have been used to detect mutations. Among these methods, direct sequencing is the gold-standard for systemic examination of mutation and for novel mutation detection (Choo-Kang et al. 2002) . In our study, we sequenced the entire mtDNA genome. For the first time, to our knowledge, we found a novel mtDNA variant, G4491A in ND2, that showed a significantly susceptibility to T2DM.
In conclusion, our findings suggested that haplogroup M9 was significantly associated with the risk of T2DM in Chinese subjects. Variants of T3394C, G4491A, T16189C and T16519C showed susceptible tendency to T2DM. Notably, mtT3394C and G4491A are specifically used for determination of haplogroup M9 in Chinese Han population. In addition, C5178A and A10398G variants seem to be genetic factors for against T2DM. These novel mtSNPs pointed out the necessity of large-scale studies and might be used for early diagnosis and prevention of T2DM in Chinese Han population. Among these variants, T3394C, G4491A, C5178A and A10398G caused amino acids replacement, which might influence mitochondria functions. Further biomedical and functional analysis on mitochondrial polymorphisms remains to be investigated. 
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